Suggested Topics within your search.
Showing 401 - 420 results of 458 for search '"Neurological disorder"', query time: 0.07s Refine Results
  1. 401

    State-of-the-art gene therapy for inherited retinal disorders by O.I. Orenburkina, A.E. Babushkin

    Published 2024-03-01
    “…The results of GRT for other neurological disorders have been obtained mostly in experimental studies. …”
    Get full text
    Article
  2. 402

    Smartphone postural sway and pronator drift tests as measures of neurological disability by Michael Calcagni, Peter Kosa, Bibi Bielekova

    Published 2025-02-01
    “…These tests capture different domains of postural control and motoric dysfunction in healthy volunteers (n = 13) and people with neurological disorders (n = 68 relapsing–remitting multiple sclerosis [MS]; n = 21 secondary progressive MS; n = 23 primary progressive MS; n = 13 other inflammatory neurological diseases; n = 21 non-inflammatory neurological diseases; n = 4 clinically isolated syndrome; n = 1 radiologically isolated syndrome). …”
    Get full text
    Article
  3. 403

    Mapping the Gaps: A Scoping Review of Virtual Care Solutions for Caregivers of Children with Chronic Illnesses by Nicole Pope, Kathyrn A. Birnie, Melanie Noel, Justine Dol, Danyu Li, Megan Macneil, Darrel Zientek, Victoria Surry, Jennifer N. Stinson

    Published 2025-01-01
    “…Most virtual care solutions targeted caregivers of children with cancer, neurological disorders, and complex chronic illnesses. Over half were noted at lower levels of stepped care (i.e., self-guided apps and websites), with psychological strategies being predominant (84%). …”
    Get full text
    Article
  4. 404

    Liposomal Formulations: A Recent Update by Surendra S. Agrawal, Vrinda Baliga, Vaishali Y. Londhe

    Published 2024-12-01
    “…This review also covers recent preclinical and clinical research showing the therapeutic promise of next-generation liposomal formulations for cancer, infectious diseases, neurological disorders and inflammatory disorders. The transfer of these innovative liposomal formulations from lab to clinical practice involves key difficulties such scalability, manufacturing difficulty, and regulatory limits.…”
    Get full text
    Article
  5. 405

    Efficient removal of lead (II) from paint factory wastewater using Noug stalk activated carbon: A sustainable adsorption approach by Getasew Yirdaw

    Published 2025-02-01
    “…Exposure to lead (II) poses serious health risks, including carcinogenic effects, neurological disorders, blood-related complications, and damage to vital organs such as the liver, kidneys, and lungs. …”
    Get full text
    Article
  6. 406

    A review of the Bovis Calculus’s intervention mechanism and clinical application in ischemic stroke by Ke Xu, Bowen Deng, Tongtong Jia, Mihong Ren, Hai Chen, Jing Zhang, Jinlin Guo, Yong Li, Jian Wang

    Published 2025-01-01
    “…BackgroundBovis Calculus (BC), also named Niuhuang in Chinese, is utilized as a resuscitation drug in Traditional Chinese Medicine (TCM) for the treatment of neurological disorders. Ischemic stroke (IS) is a significant global public health issue that currently lacks safe and effective therapeutic drugs. …”
    Get full text
    Article
  7. 407

    Advances in Stem Cell Therapy for Huntington’s Disease: A Comprehensive Literature Review by Siddharth Shah, Hadeel M. Mansour, Brandon Lucke-Wold

    Published 2025-01-01
    “…Although there is no cure at present, the discovery of the gene causing HD has brought us into a new DNA era and therapeutic advances for several neurological disorders. PubMed was systematically searched using three search strings: ‘“Huntington disease” + “stem cell”’, ‘”Huntington disease” + Mesenchymal stromal cell’, and ‘”Huntington disease” + “induced pluripotent stem cell”’. …”
    Get full text
    Article
  8. 408

    Arnold-Chiari Malformation Type II and CYP1B1 Congenital Glaucoma: A Possible Association by Shaikha Aldossari, Amani Al Bakri, Yumna Kamal

    Published 2021-01-01
    “…The main learning message here is that ACM-II patients may present with certain ocular symptoms, including glaucoma-related ones that may mimic neurological disorders. This report brings information that could alert general practitioners, neurologists, and neurosurgeons. …”
    Get full text
    Article
  9. 409
  10. 410

    Needs for rehabilitation in China: Estimates based on the Global Burden of Disease Study 1990–2019 by Tian Tian, Lin Zhu, Qingzhen Fu, Shiheng Tan, Yukun Cao, Ding Zhang, Mingxue Wang, Ting Zheng, Lijing Gao, Daria Volontovich, Yongchen Wang, Jinming Zhang, Zhimei Jiang, Hongbin Qiu, Fan Wang, Yashuang Zhao, Rongman Jia

    Published 2025-01-01
    “…The rehabilitation needs of neoplasms, cardiovascular diseases, and neurological disorders are expected to increase significantly from 2019 to 2034, with increases of 102.3%, 88.8% and 73.2%, respectively. …”
    Get full text
    Article
  11. 411

    Association of vascular endothelial growth factor B (VEGFВ) gene polymorphisms with intracranial aneurysms by R. I. Sultanova, R. I. Khusainova, E. R. Lebedeva, M. A. Yankina, D. V. Gilev, E. K. Khusnutdinova

    Published 2019-01-01
    “…The average worldwide prevalence of this disease is about 2–5 %, with 50 % of them ending in death or neurological disorders of varying severity, with a high probability of recurrence of hemorrhage during the frst half of the year after rupture. …”
    Get full text
    Article
  12. 412

    UNC-10/SYD-2 links kinesin-3 to RAB-3-containing vesicles in the absence of the motor's PH domain by Odvogmed Bayansan, Prerana Bhan, Chien-Yu Chang, Syed Nooruzuha Barmaver, Che-Piao Shen, Oliver Ingvar Wagner

    Published 2025-01-01
    “…Kinesin-3 KIF1A (UNC-104 in C. elegans) is the major axonal transporter of synaptic vesicles and mutations in this molecular motor are linked to KIF1A-associated neurological disorders (KAND), encompassing Charcot-Marie-Tooth disease, amyotrophic lateral sclerosis and hereditary spastic paraplegia. …”
    Get full text
    Article
  13. 413
  14. 414

    Protein palmitoylation is involved in regulating mouse sperm motility via the signals of calcium, protein tyrosine phosphorylation and reactive oxygen species by Yuping Xiong, Chenchen Yi, Haixia Zheng, Ya Ni, Yamei Xue, Kun Li

    Published 2025-01-01
    “…It is also implicated in the pathogenesis of diseases, such as cancer, neurological disorders, inflammation, metabolic disorders, infections, and neurodegenerative diseases. …”
    Get full text
    Article
  15. 415

    Alteration of fractional anisotropy in preterm-born individuals: a systematic review and meta-analysis by Le Zhou, Xinghui Liu, Guolin He, Meng Chen, Shuai Zeng, Chuntang Sun

    Published 2024-12-01
    “…Backgroud Neurological disorders are common in preterm (PT) born individuals. …”
    Get full text
    Article
  16. 416

    Therapeutic potential of Cinnamomum burmannii bark extract in reducing Malondialdehyde (MDA) levels in MSG-induced wistar rats: a preclinical study by Dina Afrianti, Wahyudi, Ririh Jatmi Wikandari, Rodhi Hartono, Erisa Febriyani, Egy Sunanda Putra

    Published 2024-12-01
    “…Increased consumption of monosodium glutamate (MSG) is associated with various health risks, including cardiovascular and neurological disorders. MSG triggers an increase in reactive oxygen species (ROS), the end product of lipid peroxidation produced when ROS increases is Malondialdehyde (MDA), On the other hand, interleukin 10 (IL-10) reduces the inflammatory effects in infectious conditions that can cause potential tissue damage. …”
    Get full text
    Article
  17. 417

    Comorbidities and neurosurgical interventions in a cohort with connective tissue disorders by Ilene S. Ruhoy, Paolo A. Bolognese, Jared S. Rosenblum, Randall A. Dass, Navdeep S. Nayyer, Navdeep S. Nayyer, Jeffrey D. Wood, Jeffrey D. Wood, John B. Biggins, John B. Biggins

    Published 2025-01-01
    “…Some CTDs such as hypermobile Ehlers-Danlos syndrome (hEDS), which is one of the most common, have been associated with neurological disorders requiring surgical intervention. The frequency of these comorbidities in these populations and their subsequent requirement for neurosurgical intervention remains unclear.MethodsBased on our initial experience with this population, we investigated the presentation rates of specific comorbidities and neurosurgical interventions in a cohort of individuals referred to our institution for evaluation and neurosurgical management of issues secondary to diagnosed or suspected CTDs from 2014 to 2023. …”
    Get full text
    Article
  18. 418
  19. 419

    The functional instrumental test of flexion-extension motion in the radiocarpal joint: reference parameters by Dmitry V. Skvortsov, Danila A. Lobunko, Galina Е. Ivanova

    Published 2024-12-01
    “…The research sample was a group of 15 healthy volunteers (5 males and 10 females aged from 23 to 33 years), not having any joint diseases or neurological disorders. The research was carried out within a period of one year (2022–2023). …”
    Get full text
    Article
  20. 420

    The potential of stem cell therapy in Multiple Sclerosis treatment: a review by Sorina Amarculesei, Ava O'Meara Cushen, Cathy Brougham

    Published 2023-12-01
    “…There are currently 371 clinical trials involving mesenchymal stem cells and 462 clinical trials involving adipose derived stem cells, with research focused on skeletal applications, wound healing, and to a lesser degree, haematological and neurological disorders. Although adipose derived stem cells could represent a valuable treatment option for many diseases, several drawbacks to their advancement remain, such as their pro-tumorigenic properties, possible negative alteration of the immune system, and the difficulty in assessing their migration patterns once administered in vivo. …”
    Get full text
    Article